Posts

Gene editor Scribe Therapeutics starts second-half IPO spree with $129M listing

on

Teladoc Health Takes Aim at Fragmented Healthcare With AI‑Driven Virtual Care Model

on

ADA: AZ’s oral GLP‑1 shows competitive efficacy in phase 2, setting stage for pivotal program

on

Pinnacle Medicines Secures $89M Series B Funding for Oral Peptide Pipeline

on

Insilico Medicine Secures Nearly $120M AI-Driven Cardiometabolic Drug Deal with Qilu Pharmaceutical

on

Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact

on

Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact

on

Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact

on

Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact

on

Lilly to acquire Ventyx Biosciences for ~$1.2B to add oral NLRP3 and other inflammatory drugs

on

Eli Lilly Signs Up to $2.6 Billion Deal with South Korean Biotech for RNA Medicine Delivery

on

Spotlight On Obesity Week: Non-incretin Alternatives Turn Up the Heat

on

Eli Lilly Picks Houston for $6.5 Billion API Manufacturing Facility

on

Chronic care startup Omada Health files to go public

on